Consumer durables is a cataloguing of consumer goods that are not essential to be bought very often as they are fashioned in a way so as to last for an extended period of time. Profits in the consumer durables sector were most profoundly…
BMI View: Mauritius' pharmaceutical and healthcare markets are expected to continue on a positive
growth trajectory over the forecast period. Meanwhile, Mauritius' 2016-2017 Budget is set to strengthen
manufacturing capacity in the pharmaceutical sector, including through the creation of a Pharmaceutical
Village at Rose Belle and several incentives for investors. Although revenue-earning potential from these
development initiatives will take time to materialise, Mauritius will continue to strengthen its international
reach, while gradually building its position as a research and manufacturing hub. This is illustrated by
Mauritius' growing integration with the rapidly growing economies of the East African Community, among
Headline Expenditure Projections
Pharmaceuticals: MUR6.17bn (USD176mn) in 2015 to MUR6.52bn (USD182mn) in 2016; +5.7% in local
currency terms and +3.4% in US dollar terms. Forecast revised downwards from last quarter.
Healthcare: MUR19.88bn (USD566mn) in 2015 to MUR21.05bn (USD586mn) in 2016; +5.9% growth in
local currency terms, and +3.6% in US dollar terms. Forecast revised downwards from last quarter.